Natalie Soulsby, Hugh Greville, Kingsley Coulthard, Chris Doecke

Slides:

Advertisements

Similar presentations

2015 Alzheimer's disease facts and figures Alzheimer's & Dementia: The Journal of the Alzheimer's Association Volume 11, Issue 3, Pages (March.

Advertisements

Use of the insulin pump in treat cystic fibrosis related diabetes Dana S. Hardin, Julie Rice, Mark Rice, Randall Rosenblatt Journal of Cystic Fibrosis.

Treatment compliance in children and adults with Cystic Fibrosis

Volume 64, Issue 4, Pages (October 2003)

Safety of inhaled (Tobi®) and intravenous tobramycin in young children with cystic fibrosis Stefanie Hennig, Karen McKay, Suzanna Vidmar, Katie O'Brien,

The immediate effect of musculoskeletal physiotherapy techniques and massage on pain and ease of breathing in adults with cystic fibrosis Annemarie Lee,

Development, validation, and implementation of a questionnaire assessing disease knowledge and understanding in adult cystic fibrosis patients Karen.

Volume 150, Issue 6, Pages (December 2016)

Towards an individualized protocol for workload increments in cardiopulmonary exercise testing in children and adolescents with cystic fibrosis H.J.

R. Roberts, L. Speight, J. Lee, L. George, R. I. Ketchell, D. Lau, J

GFR estimates using cystatin C are superior to serum creatinine in adult patients with cystic fibrosis Paul M. Beringer, Levita Hidayat, Anna Heed, Ling.

How does heart rate recovery after sub-maximal exercise correlate with maximal exercise testing in children with CF? Sarah P. Cohen, David M. Orenstein

Avani C. Modi, Crystal S. Lim, Nami Yu, David Geller, Mary H

Single high-dose oral vitamin D3 (stoss) therapy — A solution to vitamin D deficiency in children with cystic fibrosis? Darren Shepherd, Yvonne Belessis,

Megan R. Nelson, Craig R. Adamski, Audrey Tluczek

Helmut Ellemunter, Katharina Schüller, Gratiana Steinkamp

Urinary incontinence in 9��16��year olds with cystic fibrosis compared to other respiratory conditions and a normal group W.J. Browne, C.J. Wood, M.

Measures of body habitus are associated with lung function in adults with cystic fibrosis: A population-based study Doug L. Forrester, Alan J. Knox,

Microbiological yield from induced sputum compared to oropharyngeal swab in young children with cystic fibrosis Marco Zampoli, Komala Pillay, Henri Carrara,

Cirrhosis and other liver disease in cystic fibrosis

John Widger, Sarath Ranganathan, Philip J. Robinson

The ease of breathing test tracks clinical changes in cystic fibrosis

Renal impairment in children with cystic fibrosis

The applicability of urinary creatinine as a method of specimen normalization in the cystic fibrosis population Brandie D. Wagner, Frank J. Accurso,

Controlled clinical trials in cystic fibrosis — are we doing better?

Anju Anand, Elizabeth Tullis, Anne Stephenson, Preyanka Abhyankar

D. Stevens, P.J. Oades, N. Armstrong, C.A. Williams

Claire J. Tipping, Rebecca L. Scholes, Narelle S. Cox

Cystic fibrosis mortality trend in Italy from 1970 to 2011

Influence of digital clubbing on oxygen saturation measurements by pulse-oximetry in cystic fibrosis patients Filip Van Ginderdeuren, Karlien Van Cauwelaert,

The Journal of Cystic Fibrosis: Sunny perspectives

Spontaneous coronary artery dissection associated with coughing

Exercise-induced hypoxemia and cardiac arrhythmia in cystic fibrosis

Geriatrics American Journal of Kidney Diseases

A.H. Gifford Journal of Cystic Fibrosis

Effectiveness of inhaled tobramycin in eradicating Pseudomonas aeruginosa in children with cystic fibrosis Sanja Stanojevic, Valerie Waters, Joseph L.

M. Al-Aloul, M. Jackson, G. Bell, M. Ledson, M. Walshaw

Cystic fibrosis related diabetes in an extremely young patient

Inhalation solutions — Which ones may be mixed

Physiologic endpoints for clinical studies for cystic fibrosis

Natalie Soulsby, Hugh Greville, Kingsley Coulthard, Chris Doecke

Characterisation of mutations and genotype–phenotype correlation in cystic fibrosis: Experience from India Shivaram S. Shastri, Madhulika Kabra, Sushil.

Association between practice patterns and body mass index percentile in infants and young children with cystic fibrosis Raj Padman, Lloyd N. Werk, Gabriela.

Sophia L. Markantonis, Anna Katelari, Eleni Pappa, Stavros Doudounakis

Depression and anxiety in adolescents and adults with cystic fibrosis in the UK: A cross- sectional study Alistair J.A. Duff, Janice Abbott, Carolyn Cowperthwaite,

Anastasios Lekkas, Khin M. Gyi, Margaret E. Hodson

Prevalence and risk factors for recovery of filamentous fungi in individuals with cystic fibrosis Christopher R. Sudfeld, Elliott C. Dasenbrook, William.

Narelle S. Cox, Jennifer Follett, Karen O. McKay

Volume 70, Issue 1, Pages (July 2006)

Martin K. Kuhlmann, Martina Heckmann, Werner Riegel, Hans Köhler

Gender differences in treatment adherence among youth with cystic fibrosis: Development of a new questionnaire Joän M. Patterson, Melanie Wall, Jerica.

Segregation of children with CF diagnosed via newborn screening and acquisition of Pseudomonas aeruginosa Karen O. McKay, Peter J. Cooper, Peter P. van.

Trends in pathogens colonising the respiratory tract of adult patients with cystic fibrosis, 1985–2005 F.A. Millar, N.J. Simmonds, M.E. Hodson Journal.

A new method of sweat testing: the CF Quantum®sweat test

Within-Person Variability in Kidney Measures

Ruth H. Keogh, Sanja Stanojevic Journal of Cystic Fibrosis

Lung clearance index during hospital admission in school-age children with cystic fibrosis Liam Welsh, Christopher Nesci, Haily Tran, Marisol Tomai,

Determining presence of lung disease in young children with cystic fibrosis: Lung clearance index, oxygen saturation and cough frequency E.M. Bakker,

H. White, A.M. Morton, S.P. Conway, D.G. Peckham

J.E. Spahr, R.B. Love, M. Francois, K. Radford, K.C. Meyer

James H. Hull, Rachel Garrod, Timothy B. Ho, Ronald K. Knight, John R

D.F. Waterhouse, A.M. McLaughlin, C.G. Gallagher

‘Peeling paint’ dermatitis as a presenting sign of cystic fibrosis

Exercise-induced hypoxemia and cardiac arrhythmia in cystic fibrosis

Lutz Goldbeck, Sven Zerrer, Tim G. Schmitz Journal of Cystic Fibrosis

Khin M. Gyi, Margaret E. Hodson, Magdi Y. Yacoub

David Adeboyeku, Sandra Scott, Margaret E. Hodson

Elisabeth P. Dellon, Margaret W. Leigh, James R. Yankaskas, Terry L

Population pharmacokinetics of tobramycin administered thrice daily and once daily in children and adults with cystic fibrosis D.J. Touw, A.J. Knox,

H. White, A.M. Morton, D.G. Peckham, S.P. Conway

Presentation transcript:

What is the best method for measuring renal function in adults and children with cystic fibrosis? Natalie Soulsby, Hugh Greville, Kingsley Coulthard, Chris Doecke Journal of Cystic Fibrosis Volume 9, Issue 2, Pages 124-129 (March 2010) DOI: 10.1016/j.jcf.2009.12.002 Copyright © 2010 Terms and Conditions

Fig. 1 Bland and Altman analysis for differences between estimated GFR and measured GFR in mL/min/1.73m2. The x-axis represents the average GFR and the y-axis represents the difference between the measured GFR and creatinine based equations (Cockcroft and Gault or aMDRD for adults and Schwartz or updated Schwartz for children) measuring CrCl or Cystatin C GFR from the MacIsaac equation or tobramycin clearance. Also plotted are the mean (solid line) and the 1.96SD limits (dotted lines). Journal of Cystic Fibrosis 2010 9, 124-129DOI: (10.1016/j.jcf.2009.12.002) Copyright © 2010 Terms and Conditions

Fig. 1 Bland and Altman analysis for differences between estimated GFR and measured GFR in mL/min/1.73m2. The x-axis represents the average GFR and the y-axis represents the difference between the measured GFR and creatinine based equations (Cockcroft and Gault or aMDRD for adults and Schwartz or updated Schwartz for children) measuring CrCl or Cystatin C GFR from the MacIsaac equation or tobramycin clearance. Also plotted are the mean (solid line) and the 1.96SD limits (dotted lines). Journal of Cystic Fibrosis 2010 9, 124-129DOI: (10.1016/j.jcf.2009.12.002) Copyright © 2010 Terms and Conditions

Fig. 1 Bland and Altman analysis for differences between estimated GFR and measured GFR in mL/min/1.73m2. The x-axis represents the average GFR and the y-axis represents the difference between the measured GFR and creatinine based equations (Cockcroft and Gault or aMDRD for adults and Schwartz or updated Schwartz for children) measuring CrCl or Cystatin C GFR from the MacIsaac equation or tobramycin clearance. Also plotted are the mean (solid line) and the 1.96SD limits (dotted lines). Journal of Cystic Fibrosis 2010 9, 124-129DOI: (10.1016/j.jcf.2009.12.002) Copyright © 2010 Terms and Conditions